|
(Health-NewsWire.Net, July 20, 2024 ) InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Cell and Gene Therapy Supply Chain/Logistics Market Size, Share & Trends Analysis Report By Application area (Donor eligibility assessment, Sample collection, Manufacturing, Logistics, Patient verification, and treatment follow-up), By Type of software solution (Cell orchestration platform, Enterprise manufacturing system, Inventory management system, Laboratory information management system, Logistics management system, Patient management system, Quality management system, Tracking and tracing system ), By Mode of Deployment (Cloud-Based, On-premises ), By End-user (Biobank, Cell therapy lab, Hospital, Research institute, Commercial organization)- Market Outlook And Industry Analysis 2031"
Download Free Demo Report: https://www.insightaceanalytic.com/request-sample/1694
The cell and gene therapy supply chain/logistics is a complex system designed to effectively deliver these life-saving treatments to patients. It involves several steps, with special considerations to ensure the fragile therapies are kept safe and viable throughout the journey. Rare diseases are treated with gene and cell treatments.
Clinical trials for rare diseases will inevitably take place across many states or perhaps continents. This creates a difficulty that necessitates a robust and interconnected supply chain network, with supply chain participants working together to ensure the safe handling and transportation of temperature-sensitive cargo. The development of cell and gene therapy requires cooperation with logistics suppliers that have many logistical hubs in strategic locations in order to meet service expectations and lower cold chain risk.
Training for cell and gene therapy logistics should encompass shipping, storage, preparation, and administration of the therapies. It should also address the patient journey, coordination of treatment, cohort management, manufacturing slots, and involvement of surgical or interventional radiology.
Supply chain vendors in cell and gene therapy, such as couriers, depot networks, tracking platforms, and patient concierges, need to be integrated into the logistics oversight. A dedicated Cell and Gene Therapy (CAGT) Logistics Manager is crucial for ensuring seamless coordination of patient and asset journeys, supporting clinical trial adherence, and managing on-time delivery. This manager should also handle temperature excursions, packaging/labeling, and interactive response technology (IRT) integration, often with the help of technology platforms.
List of Prominent Players in the Cell and Gene Therapy Supply Chain/Logistics Market:
Be The Match BioTherapies
MAK-SYSTEM
Cryoport
Brooks Life Sciences
Lykan Bioscience
Clarkston Consulting
SAP
Hypertrust Patient Data Care
Haemonetics
MasterControl
TraceLink
SAVSU Technologies
TrakCel
Title21 Health Solutions
sedApta Group
Vineti
Stafa Cellular Therapy
Thermo Fisher Scientific(Patheon)
McKesson
Biocair
Marken(UPS Company)
Modality Solutions
Almac
Arvato Supply Chain Solutions SE
Catalent, Inc
BioLife Solutions, Inc
Biostor Ltd
Yourway Biopharma Services Company
Atelerix Ltd
Other Prominent Players
Market Dynamics:
Drivers-
Rising adoption of personalized therapies tailored to individual patient needs, particularly for rare and complex diseases. Growth in patient-centric approaches requiring sophisticated logistics solutions. Innovations in gene editing technologies such as CRISPR, enhance the development and delivery of cell and gene therapies. Accelerated approvals and supportive regulatory frameworks from agencies like the FDA and EMA, encourage the development and commercialization of cell and gene therapies. Increased focus on compliance and quality assurance driving the need for specialized logistics. Increased patient awareness and advocacy for access to advanced therapies driving demand and logistical needs.
Challenges:
Ensuring consistent temperature control (cold chain logistics) to maintain the viability and efficacy of therapies during transport and storage. Preventing contamination and preserving the genetic stability of the therapies throughout the supply chain.
Regional Trends:
The North America dominates the market. Leading in the adoption of advanced technologies such as AI, IoT, and blockchain for supply chain optimization and tracking. Significant investments in R&D and infrastructure for cell and gene therapy manufacturing and logistics. Strong regulatory frameworks and support from agencies like the FDA are driving innovation and adoption of cell and gene therapies. The Asia Pacific is rapidly Rapidly expanding the market for cell and gene therapies, particularly in countries like China, Japan, and South Korea. Increasing government support and investment in biotechnology and regenerative medicine.
Curious about this latest version of the report? @ https://www.insightaceanalytic.com/report/cell-and-gene-therapy-supply-chain-logistics-market/1694
Recent Developments:
In June 2024 Cryoport, Inc., declared a strategic alliance to offer biotechnology and pharmaceutical firms fully integrated manufacturing and logistics services for regenerative medicine products to help the development of cell and gene therapies.
In November 2023, BioLife Solutions, The company intends to use the USD 10.4 million it raised through a private placement to expand its supply chain services for gene and cell therapies.
In Oct. 2023, Be The Match BioTherapiesฎ, declared a fresh strategic alliance. IntegriCellTM, a standardized bioprocessing, cryopreservation, and distribution solution for the worldwide cell therapy market, will become even more capable as a result of the partnership. IntegriCellTM is prepared to support both centralized and decentralized manufacturing methods, facilitating and expediting patient access to cutting-edge novel medicines. Cryopreservation facilities are located in the EU and the US.
Segmentation of Cell and Gene Therapy Supply Chain/Logistics Market-
Application Area
Donor eligibility assessment
Sample collection
Manufacturing
Logistics
Patient verification and treatment follow-up
Type of Software Solution
Cell orchestration platform
Enterprise manufacturing system
Inventory management system
Laboratory information management system
Logistics management system
Patient management system
Quality management system
Tracking and tracing system
End-Use
Biobank
Cell Therapy Lab
Hospital
Research Institute
Commercial Organization
Type of Deployment
Cloud-Based
On-premises
By Region-
North America-
The US
Canada
Mexico
Europe-
Germany
The UK
France
Italy
Spain
Rest of Europe
Asia-Pacific-
China
Japan
India
South Korea
South East Asia
Rest of Asia Pacific
Latin America-
Brazil
Argentina
Rest of Latin America
Middle East & Africa-
GCC Countries
South Africa
Rest of the Middle East and Africa
For More Customization @ https://www.insightaceanalytic.com/customisation/1694
About Us:
InsightAce Analytic is a market research and consulting firm that enables clients to make strategic decisions. Our qualitative and quantitative market intelligence solutions inform the need for market and competitive intelligence to expand businesses. We help clients gain competitive advantage by identifying untapped markets, exploring new and competing technologies, segmenting potential markets and repositioning products. Our expertise is in providing syndicated and custom market intelligence reports with an in-depth analysis with key market insights in a timely and cost-effective manner.
Insight Ace Analytics
Diana Dsouza
+8884144123
diana.dsouza@insightaceanalytics.com
Source: EmailWire.Com 
|
